arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Humacyte, Inc.

HUMA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$0.43
▲ +3.9% Today
as of Oct 23, 14:18 ET
Last 30 days -23.55% Sep 14 → Oct 23
$0.34 $0.40 $0.47 $0.54 $0.61 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$0.41
High
$0.42
Low
$0.40
Volume
$2M
Avg Vol
$7M
Mkt Cap
$140M
P/E (TTM)
—
Beta
—
52w High
$1.78
52w Low
$0.34
Div Yield
—
Shares Out
$278M

Recent Press Releases & News last 60 days · 16 items

Oct 21 · 21:00 Zacks
Why Humacyte, Inc. (HUMA) Outpaced the Stock Market Today
Oct 19 · 21:15 Zacks
Humacyte, Inc. (HUMA) Stock Drops Despite Market Gains: Important Facts to Note
Oct 15 · 12:00 PR GlobeNewswire
Humacyte Provides Commercial Update and Highlights Rapid Acceleration of Symvess Adoption by Hospitals
▸ Show all 16 press releases & news Free account →

HUMA earnings at a glance

The options market is pricing a move of about ±25.8% after the report, a range of roughly $0.32 to $0.54 from today's $0.43. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±27.6% on average; after the most recent report on May 13, 2026 it moved +24.2%. That means options currently expect about the same movement than HUMA has typically delivered. HUMA beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 437%. The share price of $0.43 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.34
$1.78
6% of range
Avg surprise (last 4)
+3.8%
Avg reaction (last 2)
+27.6%
100% positive
Latest IV / EM
437%
EM ±25.8% · $1 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.48$-0.38$-0.28$-0.19$-0.09 Actual $-0.36Actual $-0.22Actual $-0.25Actual $-0.29Actual $-0.48Actual $-0.33Actual $-0.10Est $-0.19Actual $-0.24Est $-0.15Actual $-0.14Est $-0.17Actual $-0.09Est $-0.10Actual $-0.16 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-39M$-19M$946,975$21M$41M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.16 — — — — financials
Wed May 13, 2026Mar/2026 $-0.09 $-0.10 +10.0% +10.0% +24.2% earnings
Wed Nov 12, 2025Sep/2025 $-0.14 $-0.17 +17.6% — — earnings
Mon Aug 11, 2025Jun/2025 $-0.24 $-0.15 -60.0% — — earnings
Tue May 13, 2025Mar/2025 $-0.10 $-0.19 +47.4% — +31.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.33 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.48 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.29 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.25 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.22 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.36 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$406,000$495,000—$753,000$301,000$517,000—$0
Cost of revenue$1M$2M—$260,000$213,000$147,000—$0
Gross profit————————
Operating income$-27M$-29M—$-24M$-30M$-23M—$-30M
Net income$-37M$-18M—$-18M$-38M$39M—$-39M
EPS (diluted)$-0.16$-0.09—$-0.11$-0.24$0.28—$-0.33

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$80M$49M$50M$19M$38M$63M$45M$21M
Inventory$7M$10M$14M$18M$11M$8M$0—
Total current assets$93M$64M$68M$41M$52M$74M$48M$23M
Total assets$138M$111M$116M$92M$139M$163M$138M$115M
Long-term debt$36M$36M$35M—————
Total liabilities$107M$99M$113M$96M$135M$127M$191M$178M
Total equity$31M$12M$3M$-5M$4M$36M$-53M$-64M

Implied volatility — last 90 days

151%375%600%824%1048% Jun 07 — IV 187% · EM ±25.9%Jun 08 — IV 233% · EM ±30.8%Jun 09 — IV 170% · EM ±21.3%Jun 10 — IV 328% · EM ±38.8%Jun 11 — IV 171% · EM ±18.8%Jun 15 — IV 256% · EM ±18.5%Jun 19 — IV 208% · EM ±46.0%Jun 22 — IV 151% · EM ±31.6%Jun 24 — IV 464% · EM ±92.9%Jun 29 — IV 460% · EM ±81.6%Jun 30 — IV 335% · EM ±57.7%Jul 01 — IV 513% · EM ±85.7%Jul 02 — IV 508% · EM ±82.2%Jul 03 — IV 541% · EM ±84.5%Jul 06 — IV 463% · EM ±64.1%Jul 07 — IV 671% · EM ±88.6%Jul 08 — IV 589% · EM ±73.8%Jul 09 — IV 700% · EM ±82.7%Jul 10 — IV 760% · EM ±83.9%Jul 13 — IV 1049% · EM ±87.6%Jul 21 — IV 289% · EM ±67.1%Jul 22 — IV 268% · EM ±61.3%Jul 23 — IV 521% · EM ±117.2%Jul 24 — IV 285% · EM ±63.0%Jul 27 — IV 249% · EM ±51.9%Jul 28 — IV 232% · EM ±47.6%Jul 29 — IV 544% · EM ±108.9%Jul 30 — IV 494% · EM ±96.9%Jul 31 — IV 275% · EM ±52.6%Aug 03 — IV 491% · EM ±87.0%Aug 04 — IV 363% · EM ±62.6%Aug 05 — IV 451% · EM ±75.3%Aug 06 — IV 348% · EM ±56.3%Aug 07 — IV 401% · EM ±62.7%Aug 10 — IV 448% · EM ±62.0%Aug 11 — IV 571% · EM ±75.4%Aug 12 — IV 419% · EM ±52.5%Aug 13 — IV 432% · EM ±51.1%Aug 14 — IV 299% · EM ±33.1%Aug 17 — IV 534% · EM ±44.6%Aug 19 — IV 920% · EM ±54.3%Aug 24 — IV 179% · EM ±37.4%Aug 25 — IV 425% · EM ±87.0%Aug 26 — IV 255% · EM ±51.2%Aug 27 — IV 252% · EM ±49.4%Aug 28 — IV 279% · EM ±53.4%Aug 31 — IV 232% · EM ±41.1%Sep 01 — IV 255% · EM ±43.8%Sep 02 — IV 251% · EM ±41.9%Sep 03 — IV 304% · EM ±49.2%Sep 04 — IV 212% · EM ±33.1%Sep 07 — IV 239% · EM ±33.1%Sep 08 — IV 252% · EM ±33.2%Sep 09 — IV 413% · EM ±51.8%Sep 10 — IV 294% · EM ±34.7%Sep 11 — IV 478% · EM ±52.9%Sep 14 — IV 319% · EM ±26.7%Sep 15 — IV 369% · EM ±26.7%Sep 16 — IV 437% · EM ±25.8%

Sector peers

MOLN
Molecular Partners AG
$143M $3.67-1.3%
CRBU
Caribou Biosciences, Inc.
$131M $0.540.0%
ABOS
Acumen Pharmaceuticals, Inc.
$150M $1.98-2.7%
ENGN
enGene Therapeutics Inc.
$128M $1.56-4.3%
TNYA
Tenaya Therapeutics, Inc.
$127M $0.39+0.3%
CHRS
Coherus Oncology, Inc.
$156M $1.01-1.0%

HUMA earnings FAQ

What is HUMA's expected move for earnings?

Options currently price a move of about ±25.8%, or $0.11 per share either way from $0.43.

How does HUMA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±27.6%, up 2 times and down 0 times.

What is HUMA's implied volatility?

HUMA's at-the-money implied volatility is about 437% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in